Commission finalises "minimum requirements" for many EU pharmacovigilance activities
This article was originally published in SRA
Executive Summary
The European Commission has issued an implementing regulation specifying the minimum requirements for various pharmacovigilance-related activities that drug companies, regulatory authorities and the European Medicines Agency will have to observe in the "daily practice" of applying the EU pharmacovigilance legislation from July 20121,2.
You may also be interested in...
Global Pharma Guidance Tracker – March 2024
Stay up to date on regulatory guidelines from around the world with the Pink Sheet's Guidance Tracker. The complete Global Pharma Guidance Tracker, with sortable and searchable listings going back to 2014, is available online.
EU Regulators Explain How To Ensure Transitioned Trials Align With CTR
Members of the EU’s Clinical Trials Coordination Group have developed harmonized requirements for updating trials that are transitioned to the Clinical Trials Information System based on a minimum set of documents.
Global Medtech Guidance Tracker: March 2024
Stay current on regulatory guidelines from around the world with Medtech Insight's Guidance Tracker. Fifty-nine documents have been posted on the tracker since its last update.